Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...

Ark Invest, through its ARK Fintech Innovation ETF ARKF -5.46% + Free Alerts , bought 162,143 shares of Nu Holdings Ltd. This marks a significant investment in the fintech company, reflecting Ark’s ...

EST Cathie Wood’s ARK Investment buys 171K shares of Beam Therapeutics (BEAM) todayDiscover the Best Stocks and Maximize Your Portfolio: ...

What do rope winding and giant pasta shapes have to do with particle physics? The answer is a new superconducting magnet ...

Cathie Wood, head of Ark Investment Management, actively trades her favorite stocks, picking her spots whether the prices are ...

New data show that external-beam radiation therapy yielded superior local control and progression-free survival vs TACE in ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...

In a move that caught the attention of investors, ARK significantly increased its holdings in Beam Therapeutics Inc (NASDAQ:BEAM), purchasing a total of 170,778 shares valued at approximately $5. ...

In addition to Twist Bioscience, ARK also increased its stake in Beam Therapeutics Inc (NASDAQ:BEAM) by acquiring a combined 47,127 shares across its ARKK and ARKG ETFs, valued at $1,526,914.